Elevated eosinophil count is related with lower anti-factor Xa activity in COVID-19 patients.

Ari, Selma; Can, Veysi; Demir, Ömer Furkan; Ari, Hasan; Agca, Fahriye Vatansever; Melek, Mehmet; Çamci, Sencer; Dikis, Özlem Sengören; Huysal, Kagan; Türk, Tamer

Ari, Selma; Can, Veysi; Demir, Ömer Furkan; Ari, Hasan; Agca, Fahriye Vatansever; Melek, Mehmet; Çamci, Sencer; Dikis, Özlem Sengören; Huysal, Kagan; Türk, Tamer.

Afiliación

Ari S; Department of Cardiology, Bursa Postgraduate Hospital, Bursa, Turkey.
Can V; Department of Cardiology, Bursa Postgraduate Hospital, Bursa, Turkey.
Demir ÖF; Department of Cardiology, Bursa Postgraduate Hospital, Bursa, Turkey.
Ari H; Department of Cardiology, Bursa Postgraduate Hospital, Bursa, Turkey.
Agca FV; Department of Cardiology, Bursa Postgraduate Hospital, Bursa, Turkey.
Melek M; Department of Cardiology, Bursa Postgraduate Hospital, Bursa, Turkey.
Çamci S; Department of Cardiology, Bursa Postgraduate Hospital, Bursa, Turkey.
Dikis ÖS; Department of Pulmonary Diseases, Bursa Postgraduate Hospital, Bursa, Turkey.
Huysal K; Department of Biochemistry, Bursa Postgraduate Hospital, Bursa, Turkey.
Türk T; Department of Cardiovascular Surgery, Bursa Postgraduate Hospital, Bursa, Turkey.

J Hematop ; 13(4): 249-258, 2020 Dec.

Article en En | MEDLINE | ID: mdl-33046998

Palabras clave

Anticoagulants; COVID-19; Eosinophils; Heparin; Thrombosis

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: J Hematop Año: 2020 Tipo del documento: Article País de afiliación: Turquía Pais de publicación: Alemania

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google